fura-2 has been researched along with Heart Failure in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chang, R; Cui, B; Fan, Z; Hiram, R; Huang, C; Huang, H; Liu, T; Shi, S; Su, X; Tang, Y; Wu, G; Wu, J; Xiong, F; Yan, M; Zhang, W | 1 |
Alsanosi, S; Bird, GS; D'Agostin, D; Lip, S; Padmanabhan, S; Parekh, AB | 1 |
Chen, YH; Jiang, B; Li, F; Li, J; Liang, D; Liu, Y; Peng, L; Xiao, J; Yan, B; Yu, Z; Zhang, G; Zhang, H; Zhang, Y; Zhou, ZN | 1 |
Bevensee, MO; Bradley, WE; DeAndrade, KB; Dell'Italia, LJ; Lucchesi, PA; McNicholas-Bevensee, CM | 1 |
Enomoto, K; Honda, M; Ishinaga, Y; Kuramochi, T; Kuzuo, H; Morioka, S; Takabatake, T; Tanaka, K | 1 |
Christensen, G; Holt, E; Lunde, PK; Sejersted, OM; Semb, SO; Tønnessen, T; Wasserstrom, JA | 1 |
Brixius, K; Reicke, S; Schwinger, RH | 1 |
Beuckelmann, DJ; Erdmann, E; Näbauer, M | 1 |
1 review(s) available for fura-2 and Heart Failure
Article | Year |
---|---|
A Reappraisal of the Effects of L-type Ca
Topics: Amlodipine; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Dihydropyridines; Fura-2; Heart Failure; Humans; Hypertension; Prospective Studies | 2023 |
1 trial(s) available for fura-2 and Heart Failure
Article | Year |
---|---|
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Calcium; Connexin 43; Disease Models, Animal; Fura-2; Glucose; Glucosides; Heart Failure; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Sodium; Ventricular Dysfunction, Right; Ventricular Remodeling | 2022 |
6 other study(ies) available for fura-2 and Heart Failure
Article | Year |
---|---|
Inhibition of mitochondrial translocator protein prevents atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Cell Line; Fluorescent Dyes; Fura-2; Heart; Heart Atria; Heart Failure; Mitochondrial Proteins; Models, Cardiovascular; Rabbits; Random Allocation | 2010 |
Activation of gadolinium-sensitive ion channels in cardiomyocytes in early adaptive stages of volume overload-induced heart failure.
Topics: Action Potentials; Adaptation, Physiological; Animals; Calcium; Fluorescent Dyes; Fura-2; Gadolinium; Heart Failure; Heart Ventricles; Intercellular Signaling Peptides and Proteins; Ion Channels; Microscopy, Fluorescence; Models, Animal; Myocytes, Cardiac; Patch-Clamp Techniques; Peptides; Perfusion; Rats; Spider Venoms; Stimulation, Chemical; Stress, Mechanical; Time Factors | 2006 |
Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Fura-2; Heart; Heart Failure; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Monocrotaline; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Sprague-Dawley | 1994 |
Mechanisms of cardiomyocyte dysfunction in heart failure following myocardial infarction in rats.
Topics: Actin Cytoskeleton; Animals; Calcium; Calcium Channels; Calcium-Transporting ATPases; Colforsin; Fura-2; Heart Failure; Heart Ventricles; Hemodynamics; Male; Muscle Contraction; Myocardial Infarction; Myocardium; Patch-Clamp Techniques; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Sodium; Thapsigargin | 1998 |
Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium.
Topics: Calcium; Cardiotonic Agents; Cyclic AMP; Fluorescent Dyes; Fura-2; Heart; Heart Failure; Heart Transplantation; Humans; Hydrazones; In Vitro Techniques; Isoproterenol; Muscle Fibers, Skeletal; Muscle Relaxation; Myocardial Contraction; Pyridazines; Reference Values; Simendan; Systole; Ventricular Function, Left | 2002 |
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.
Topics: Action Potentials; Calcium; Calcium Channels; Cells, Cultured; Cyclic AMP; Electric Conductivity; Female; Fura-2; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium | 1992 |